ASCO Guidelines
Un podcast de American Society of Clinical Oncology (ASCO)
180 Épisodes
-
Endocrine Treatment and Targeted Therapy for Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer Guideline Update
Publié: 29/07/2021 -
Chemotherapy and Targeted Therapy for Patients with Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer That is Either Endocrine-Pretreated or Hormone Receptor-Negative Guidelin
Publié: 29/07/2021 -
Telehealth in Oncology: Standards and Practice Recommendations
Publié: 28/07/2021 -
Salivary Gland Hypofunction and/or Xerostomia Induced by Non-Surgical Cancer Therapies: ISOO/MASCC/ASCO Guideline
Publié: 20/07/2021 -
Management of the Axilla in Early-Stage Breast Cancer: OH (CCO) and ASCO Guideline
Publié: 19/07/2021 -
Oncology Medical Home: ASCO and COA Standards
Publié: 13/07/2021 -
Assessment of Adult Women with Ovarian Masses and Treatment of Epithelial Ovarian Cancer Resource Stratified Guideline
Publié: 29/06/2021 -
Appropriate Systemic Therapy Dosing for Obese Adult Patients with Cancer Guideline Update
Publié: 03/05/2021 -
Management of Salivary Gland Malignancy Guideline
Publié: 26/04/2021 -
Management of Dyspnea in Advanced Cancer Guideline
Publié: 22/02/2021 -
Therapy for Stage IV Non–Small-Cell Lung Cancer With Driver Alterations: ASCO and OH (CCO) Guideline Update
Publié: 16/02/2021 -
Neoadjuvant Chemotherapy, Endocrine Therapy, and Targeted Therapy for Breast Cancer Guideline
Publié: 28/01/2021 -
Radiation Therapy for Small Cell Lung Cancer Guideline Endorsement
Publié: 27/01/2021 -
Initial Management of Non-Castrate Advanced, Recurrent, or Metastatic Prostate Cancer Guideline Update
Publié: 26/01/2021 -
PREVIEW: ASCO in Action CEO & CMO Interview
Publié: 19/01/2021 -
Chemotherapy in Combination with Radiotherapy for Definitive-intent Treatment of Stage II to IVA Nasopharyngeal Carcinoma: CSCO-ASCO Guideline
Publié: 06/01/2021 -
Systemic Therapy for Advanced Hepatocellular Carcinoma Guideline
Publié: 16/11/2020 -
Selection of Optimal Adjuvant Chemotherapy and Targeted Therapy for Early Breast Cancer Guideline Update
Publié: 20/10/2020 -
Treatment of Metastatic Carcinoma and Myeloma of the Femur: Joint MSTS/ASTRO/ASCO Guideline
Publié: 01/10/2020 -
PARP Inhibitors in the Management of Ovarian Cancer Guideline
Publié: 13/08/2020
Explore pivotal recommendations from the latest evidence-based clinical practice guidance with ASCO Guidelines. Join us to discover essential insights and navigate the ever-evolving landscape of cancer research and treatment.
